Harley-Davidson Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Harley-Davidson Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-25 | 2022-06-26 | 2022-03-27 | 2021-12-31 | 2021-09-26 | 2021-06-27 | 2021-03-28 | 2020-12-31 | 2020-09-27 | 2020-06-28 | 2020-03-29 | 2019-12-31 | 2019-09-29 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-07-01 | 2018-04-01 | 2017-12-31 | 2017-09-24 | 2017-06-25 | 2017-03-26 | 2016-12-31 | 2016-09-25 | 2016-06-26 | 2016-03-27 | 2015-12-31 | 2015-09-27 | 2015-06-28 | 2015-03-29 | 2014-12-31 | 2014-03-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-07-01 | 2012-04-01 | 2011-12-31 | 2011-09-25 | 2011-06-26 | 2011-03-27 | 2010-12-31 | 2010-09-26 | 2010-06-27 | 2010-03-28 | 2009-12-31 | 2009-09-27 | 2009-06-28 | 2009-03-29 | 2008-12-31 | 2008-09-28 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net cash from operating activities | 367,958,000 | 141,534,000 | 133,178,000 | 353,013,000 | 473,645,000 | 103,997,000 | 48,120,000 | 296,247,000 | 363,843,000 | 46,677,000 | -26,243,000 | 330,518,000 | 104,865,000 | 139,321,000 | 50,150,000 | 281,251,000 | 42,822,000 | 524,865,000 | 19,623,000 | 352,417,000 | 463,561,000 | 32,671,000 | 83,366,000 | 386,696,000 | 544,265,000 | 191,594,000 | 55,986,000 | 322,007,000 | 467,129,000 | 159,939,000 | 246,530,000 | 471,519,000 | 415,159,000 | 41,131,000 | 79,161,000 | 407,013,000 | 439,244,000 | 174,700,000 | 179,809,000 | |||||||||||||||||||||||||
cash flows from investing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
capital expenditures | -35,587,000 | -29,973,000 | -56,139,000 | -52,589,000 | -41,479,000 | -46,356,000 | -68,502,000 | -52,376,000 | -41,412,000 | -45,114,000 | -66,722,000 | -29,932,000 | -27,016,000 | -27,999,000 | -58,705,000 | -23,908,000 | -18,755,000 | -18,813,000 | -38,755,000 | -25,269,000 | -34,098,000 | -32,928,000 | -60,279,000 | -37,932,000 | -47,974,000 | -35,255,000 | -93,671,000 | -50,552,000 | -40,857,000 | -28,436,000 | -92,272,000 | -44,206,000 | -45,849,000 | -23,967,000 | -93,537,000 | -55,195,000 | -68,520,000 | -39,011,000 | -120,920,000 | -53,874,000 | -47,111,000 | -38,069,000 | -112,003,000 | -25,881,000 | -44,328,000 | -22,261,000 | -93,673,000 | -35,251,000 | -35,398,000 | -24,680,000 | -82,920,000 | -36,848,000 | -41,563,000 | -27,704,000 | -93,286,000 | -31,805,000 | -31,196,000 | -14,558,000 | -27,337,000 | -32,088,000 | -34,402,000 | -22,921,000 | -78,482,000 | -54,090,000 |
free cash flows | 332,371,000 | 111,561,000 | 77,039,000 | 300,424,000 | 432,166,000 | 57,641,000 | -20,382,000 | 243,871,000 | 322,431,000 | 1,563,000 | -92,965,000 | 300,586,000 | 77,849,000 | 111,322,000 | -8,555,000 | 257,343,000 | 4,067,000 | 499,596,000 | -40,656,000 | 314,485,000 | 415,587,000 | -2,584,000 | -10,305,000 | 336,144,000 | 503,408,000 | 163,158,000 | -36,286,000 | 277,801,000 | 421,280,000 | 135,972,000 | 152,993,000 | 416,324,000 | 346,639,000 | 2,120,000 | -41,759,000 | 353,139,000 | 392,133,000 | 136,631,000 | 67,806,000 | |||||||||||||||||||||||||
origination of finance receivables | -1,029,150,000 | -736,801,000 | -636,542,000 | -906,785,000 | -1,188,183,000 | -907,769,000 | -710,585,000 | -1,033,974,000 | -1,211,838,000 | -917,145,000 | -785,004,000 | -1,262,637,000 | -1,452,732,000 | -1,058,461,000 | -798,757,000 | -1,150,453,000 | -1,385,362,000 | -909,138,000 | -624,227,000 | -1,003,690,000 | -1,089,508,000 | -780,061,000 | -705,696,000 | -1,076,727,000 | -1,213,527,000 | -851,372,000 | -713,657,000 | -1,039,374,000 | -1,201,719,000 | -798,067,000 | -664,576,000 | -949,533,000 | -1,133,147,000 | -844,692,000 | -655,016,000 | -1,018,095,000 | -1,175,687,000 | -815,697,000 | -639,003,000 | -1,136,264,000 | -1,224,159,000 | -752,404,000 | -649,542,000 | -757,965,000 | -1,030,859,000 | -622,373,000 | -530,048,000 | -745,081,000 | -938,325,000 | -645,247,000 | ||||||||||||||
collections on finance receivables | 912,968,000 | 827,998,000 | 870,185,000 | 945,050,000 | 841,914,000 | 920,385,000 | 978,611,000 | 890,852,000 | 824,120,000 | 1,038,929,000 | 1,106,762,000 | 965,190,000 | 933,907,000 | 1,024,033,000 | 1,043,879,000 | 900,485,000 | 810,123,000 | 944,468,000 | 944,437,000 | 841,261,000 | 803,799,000 | 927,089,000 | 953,005,000 | 815,824,000 | 760,974,000 | 851,811,000 | 903,084,000 | 809,800,000 | 748,189,000 | 832,323,000 | 866,645,000 | 781,154,000 | 734,565,000 | 810,253,000 | 858,303,000 | 771,910,000 | 743,530,000 | 822,924,000 | 840,765,000 | 729,666,000 | 705,008,000 | 707,431,000 | 757,168,000 | 665,520,000 | 637,064,000 | 695,235,000 | 753,886,000 | 681,904,000 | 629,680,000 | |||||||||||||||
other investing activities | 520,000 | 171,000 | 12,337,000 | 41,000 | 83,000 | -289,000 | -3,058,000 | 28,000 | 29,000 | 821,000 | 331,000 | 1,363,000 | 662,000 | 135,000 | -345,000 | 60,000 | 1,692,000 | 733,000 | 21,130,000 | 715,000 | -397,000 | 16,000 | 5,524,000 | |||||||||||||||||||||||||||||||||||||||||
net cash used by investing activities | 102,847,000 | -89,148,000 | -284,529,000 | -112,500,000 | -1,171,000 | -165,937,000 | -274,610,000 | -70,586,000 | -27,275,000 | -252,277,000 | -372,324,000 | -121,135,000 | 76,100,000 | -150,268,000 | 168,271,000 | -83,776,000 | 43,348,000 | -186,899,000 | -287,375,000 | -77,200,000 | -46,206,000 | -248,110,000 | -346,302,000 | -21,651,000 | -8,468,000 | -161,175,000 | -305,372,000 | -87,453,000 | -13,828,000 | -262,938,000 | -33,262,000 | -82,703,000 | -12,084,000 | -422,063,000 | -420,903,000 | -60,798,000 | -54,975,000 | -507,934,000 | -47,992,000 | -12,124,000 | ||||||||||||||||||||||||
cash flows from financing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of medium-term notes | 0 | 647,088,000 | 0 | 0 | 0 | 0 | 753,028,000 | 693,276,000 | 0 | 0 | 0 | 495,785,000 | 0 | 0 | 656,581,000 | 0 | 0 | 546,655,000 | 447,810,000 | 0 | 796,465,000 | 347,553,000 | 0 | 0 | 396,262,000 | 497,406,000 | 0 | 0 | 0 | 1,193,396,000 | 0 | 0 | 0 | 595,386,000 | 397,404,000 | 0 | 596,364,000 | -4,000 | 397,377,000 | -52,799,000 | 0 | 447,076,000 | 0 | |||||||||||||||||||||
repayments of medium-term notes | 0 | 0 | -706,680,000 | -350,000,000 | 0 | 0 | -400,000,000 | -550,000,000 | 0 | 0 | -350,000,000 | -1,050,000,000 | 0 | 0 | -800,000,000 | -600,000,000 | 0 | -600,000,000 | 0 | -750,000,000 | 0 | 0 | -400,000,000 | 0 | 0 | -400,000,000 | 0 | -1,336,000 | 0 | -450,000,000 | -10,331,000 | -519,211,000 | ||||||||||||||||||||||||||||||||
proceeds from securitization debt | 0 | 597,593,000 | 0 | 497,841,000 | 0 | 547,706,000 | 0 | 0 | 0 | 572,499,000 | 0 | 597,411,000 | 0 | 0 | 1,541,756,000 | 522,694,000 | 100,000 | 0 | 0 | 0 | 498,077,000 | 697,591,000 | 0 | 0 | 672,865,000 | 511,323,000 | 1,218,063,000 | 697,358,000 | ||||||||||||||||||||||||||||||||||||
repayments of securitization debt | -291,482,000 | -292,671,000 | -296,087,000 | -275,672,000 | -272,311,000 | -234,178,000 | -262,918,000 | -285,231,000 | -334,737,000 | -310,640,000 | -387,921,000 | -444,734,000 | -338,706,000 | -271,499,000 | -326,818,000 | -349,135,000 | -373,339,000 | -291,346,000 | -305,866,000 | -366,272,000 | -238,695,000 | -130,918,000 | -109,001,000 | -130,444,000 | -37,301,000 | -76,505,000 | -33,362,000 | -41,054,000 | -115,498,000 | -67,955,000 | -77,373,000 | -91,639,000 | -164,300,000 | -111,359,000 | -129,784,000 | -149,779,000 | -212,474,000 | -173,363,000 | -243,226,000 | -310,577,000 | -253,637,000 | -200,695,000 | -203,554,000 | -159,938,000 | -244,532,000 | -178,923,000 | -244,007,000 | -322,191,000 | -506,375,000 | -333,026,000 | -421,027,000 | -431,690,000 | -471,380,000 | -430,471,000 | -378,137,000 | -511,257,000 | -562,056,000 | -445,215,000 | -156,733,000 | -92,443,000 | ||||
borrowings of asset-backed commercial paper | 0 | 155,000,000 | 103,815,000 | 14,742,000 | 16,868,000 | 334,561,000 | 0 | 8,882,000 | 0 | 23,002,000 | 362,798,000 | 62,455,000 | 71,457,000 | 0 | 0 | 0 | 225,187,000 | 0 | 154,577,000 | 388,839,000 | 0 | 85,399,000 | 35,504,000 | 98,679,000 | 29,628,000 | 36,416,000 | 305,209,000 | 28,968,000 | 0 | 27,614,000 | 5,814,000 | 18,251,000 | 28,982,000 | 23,411,000 | 16,798,000 | 27,238,000 | 13,746,000 | |||||||||||||||||||||||||||
repayments of asset-backed commercial paper | -80,375,000 | -65,004,000 | -62,368,000 | -70,055,000 | -79,500,000 | -46,154,000 | -49,771,000 | -57,638,000 | -67,327,000 | -62,634,000 | -74,491,000 | -95,272,000 | -76,525,000 | -56,634,000 | -54,696,000 | -63,415,000 | -76,362,000 | -66,894,000 | -81,982,000 | -93,540,000 | -75,497,000 | -67,809,000 | -77,998,000 | -84,722,000 | -82,885,000 | -72,401,000 | -56,471,000 | -55,598,000 | -54,753,000 | -45,907,000 | -46,537,000 | -51,958,000 | -48,349,000 | -29,383,000 | -16,330,000 | -20,181,000 | -19,249,000 | -15,740,000 | -17,603,000 | -19,394,000 | -19,986,000 | -15,744,000 | -19,083,000 | -16,981,000 | ||||||||||||||||||||
net decrease in unsecured commercial paper | -9,609,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net increase in deposits | 1,382,000 | 44,730,000 | 62,765,000 | -6,758,000 | -31,302,000 | 38,869,000 | 70,466,000 | 51,822,000 | -27,475,000 | -1,175,000 | -2,405,000 | 57,660,000 | -32,000 | 30,815,000 | 106,665,000 | 72,664,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
dividends paid | -21,835,000 | -22,921,000 | -21,770,000 | -22,095,000 | -22,974,000 | -24,385,000 | -23,535,000 | -24,582,000 | -24,070,000 | -24,123,000 | -23,017,000 | -23,017,000 | -23,090,000 | -24,056,000 | -23,110,000 | -23,107,000 | -23,104,000 | -23,105,000 | -3,085,000 | -3,085,000 | -3,100,000 | -58,817,000 | -57,812,000 | -58,568,000 | -59,982,000 | -60,859,000 | -59,705,000 | -61,425,000 | -61,949,000 | -62,731,000 | -61,741,000 | -61,669,000 | -63,841,000 | -64,611,000 | -61,934,000 | -62,587,000 | -63,343,000 | -64,457,000 | -57,811,000 | -61,706,000 | -64,278,000 | -65,467,000 | -58,440,000 | -60,527,000 | -46,905,000 | -47,308,000 | ||||||||||||||||||
repurchase of common stock | -45,000 | -93,095,000 | -100,019,000 | -150,135,000 | -101,863,000 | -107,812,000 | -124,559,000 | -69,783,000 | -72,878,000 | -96,767,000 | -131,000 | -12,668,000 | -64,091,000 | -261,737,000 | -78,000 | -634,000 | -5,265,000 | -5,646,000 | -111,000 | -739,000 | -85,000 | -7,071,000 | -79,066,000 | |||||||||||||||||||||||||||||||||||||||||
other financing activities | 1,000 | 5,000 | 0 | 3,000 | 1,000 | 7,000 | 240,000 | 1,630,000 | 7,000 | 69,000 | -748,000 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash (used) provided by financing activities | -25,925,000 | -333,385,000 | 194,819,000 | -733,646,000 | -1,012,719,000 | -98,930,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
effect of exchange rate changes on cash, cash equivalents and restricted cash | 9,076,000 | 3,299,000 | -16,343,000 | 11,019,000 | -3,801,000 | -7,020,000 | 10,112,000 | -7,925,000 | -4,310,000 | 3,820,000 | 13,836,000 | -18,948,000 | -12,670,000 | -1,743,000 | -4,222,000 | -4,172,000 | -1,715,000 | -5,163,000 | 12,641,000 | 6,453,000 | 5,350,000 | -5,732,000 | 1,805,000 | -7,549,000 | 3,848,000 | -409,000 | -2,784,000 | -2,476,000 | -12,125,000 | 2,034,000 | ||||||||||||||||||||||||||||||||||
net increase in cash, cash equivalents and restricted cash | -340,919,000 | 356,413,000 | -666,093,000 | 406,346,000 | 393,238,000 | -41,448,000 | -371,161,000 | 351,125,000 | -68,831,000 | 158,501,000 | -463,113,000 | -404,180,000 | -211,357,000 | 321,630,000 | -612,388,000 | -881,834,000 | -332,960,000 | -325,418,000 | 2,492,698,000 | 669,482,000 | -43,757,000 | -64,775,000 | 214,767,000 | -460,617,000 | 289,737,000 | -59,672,000 | 210,426,000 | 73,047,000 | ||||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash, beginning of period | 0 | 1,740,854,000 | 0 | 0 | 0 | 1,648,811,000 | 0 | 0 | 0 | 1,579,177,000 | 0 | 0 | 0 | 2,025,219,000 | 0 | 0 | 0 | 3,409,168,000 | 0 | 0 | 0 | 905,366,000 | 0 | |||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash, end of period | -340,919,000 | 2,097,267,000 | -666,093,000 | 406,346,000 | 393,238,000 | 1,607,363,000 | -371,161,000 | 351,125,000 | -68,831,000 | 1,737,678,000 | -463,113,000 | -404,180,000 | 888,313,000 | 1,558,157,000 | -211,357,000 | 321,630,000 | -612,388,000 | 2,527,334,000 | -332,960,000 | -325,418,000 | 2,492,698,000 | 1,574,848,000 | -43,757,000 | |||||||||||||||||||||||||||||||||||||||||
reconciliation of cash, cash equivalents and restricted cash on the consolidated balance sheets to the consolidated statements of cash flows: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents | -343,511,000 | 1,931,175,000 | -654,302,000 | 394,751,000 | 384,545,000 | 1,464,614,000 | -344,545,000 | 356,411,000 | -39,260,000 | 1,561,200,000 | -297,075,000 | -464,009,000 | 800,528,000 | 1,393,731,000 | -186,558,000 | 319,335,000 | -578,677,000 | 2,320,645,000 | -303,747,000 | -295,647,000 | 2,391,536,000 | 1,465,061,000 | -28,513,000 | -62,257,000 | 175,038,000 | 749,600,000 | 276,774,000 | -51,757,000 | 225,232,000 | 753,517,000 | ||||||||||||||||||||||||||||||||||
restricted cash | -350,000 | 150,132,000 | -12,249,000 | 10,424,000 | 7,741,000 | 129,745,000 | -26,196,000 | -4,780,000 | -29,347,000 | 164,965,000 | -151,840,000 | 60,776,000 | 83,676,000 | 142,812,000 | -24,938,000 | 1,462,000 | -32,963,000 | 185,374,000 | -28,513,000 | -29,557,000 | 89,809,000 | 99,903,000 | -14,561,000 | -3,133,000 | 38,777,000 | 43,471,000 | 12,804,000 | -7,915,000 | -10,183,000 | 54,569,000 | ||||||||||||||||||||||||||||||||||
restricted cash included in other long-term assets | 2,942,000 | 15,960,000 | 458,000 | 1,171,000 | 952,000 | 13,004,000 | -420,000 | -506,000 | -224,000 | 11,513,000 | -14,198,000 | -947,000 | 4,109,000 | 21,614,000 | 139,000 | 833,000 | -748,000 | 21,315,000 | -700,000 | -214,000 | 11,353,000 | 9,884,000 | -683,000 | 615,000 | 952,000 | 6,060,000 | 159,000 | 0 | -4,623,000 | 11,171,000 | ||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash per the consolidated statements of cash flows | -340,919,000 | 2,097,267,000 | -666,093,000 | 406,346,000 | 393,238,000 | 1,607,363,000 | -371,161,000 | 351,125,000 | -68,831,000 | 1,737,678,000 | -463,113,000 | -404,180,000 | 888,313,000 | 1,558,157,000 | -211,357,000 | 321,630,000 | -612,388,000 | 2,527,334,000 | -332,960,000 | -325,418,000 | 2,492,698,000 | 1,574,848,000 | -43,757,000 | |||||||||||||||||||||||||||||||||||||||||
net cash provided (used) by investing activities | 61,395,000 | 28,288,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net increase in unsecured commercial paper | -140,778,000 | 150,052,000 | 58,794,000 | 63,623,000 | -270,119,000 | 64,521,000 | 1,728,000 | 474,000 | 65,000 | -262,517,000 | -65,598,000 | -321,376,000 | 59,146,000 | 772,208,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
net decrease in deposits | -37,439,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash provided (used) by financing activities | 150,185,000 | 178,590,000 | -463,473,000 | -556,694,000 | -772,960,000 | 2,048,129,000 | 655,508,000 | 108,293,000 | 42,197,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
collections of finance receivables | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash received from business combination | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash used by financing activities | -483,505,000 | -108,533,000 | -222,744,000 | 34,733,000 | -415,679,000 | 255,361,000 | -195,782,000 | -41,061,000 | -482,534,000 | -186,730,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from financing activities | 131,462,000 | 228,740,000 | 11,000 | 10,295,000 | 335,722,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deposit in advance of business combination | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net increase in credit facilities | -15,545,000 | 15,629,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net decrease in cash, cash equivalents and restricted cash | -467,062,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issuance of common stock under share-based plans | 0 | 3,239,000 | 1,085,000 | -7,000 | 55,000 | 7,000 | 34,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash provided | 162,781,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash (used) provided by investing activities | -26,733,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of marketable securities | 0 | 0 | 0 | 0 | -137,653,000 | -5,000,000 | -115,868,000 | -7,827,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
sales and redemptions of marketable securities | 0 | 0 | 0 | 0 | 0 | 14,000 | 2,007,000 | 5,000,000 | 0 | 6,001,000 | 250,000 | 0 | 3,004,000 | 20,042,000 | 25,146,000 | 65,009,000 | 9,992,000 | 29,974,000 | 29,638,000 | 41,053,000 | 524,000 | 0 | ||||||||||||||||||||||||||||||||||||||||||
acquisition of business | 0 | 0 | 0 | -7,000,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deposits | 49,955,000 | 11,997,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash | -8,582,000 | -104,918,000 | -244,619,000 | -463,427,000 | -182,206,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net increase in credit facilities and unsecured commercial paper | -442,746,000 | 607,899,000 | -787,133,000 | 58,527,000 | -237,510,000 | 45,874,000 | 516,000 | 210,739,000 | -661,241,000 | 379,223,000 | 307,803,000 | -161,803,000 | 392,564,000 | -109,850,000 | -588,245,000 | 55,769,000 | 51,019,000 | -115,112,000 | 107,452,000 | 88,938,000 | -50,703,000 | 48,442,000 | ||||||||||||||||||||||||||||||||||||||||||
issuance of common stock under employee stock option plans | 1,409,000 | 1,347,000 | 217,000 | 616,000 | 368,000 | 1,192,000 | 246,000 | 1,719,000 | 3,469,000 | 452,000 | 96,000 | 7,336,000 | 9,338,000 | 4,077,000 | 2,091,000 | 276,000 | 3,424,000 | 1,091,000 | 6,059,000 | 9,605,000 | 8,935,000 | 8,894,000 | 10,790,000 | 13,887,000 | 9,631,000 | 1,005,000 | 19,056,000 | 16,281,000 | 77,000 | 3,229,000 | 673,000 | 3,861,000 | 379,000 | 282,000 | 6,083,000 | 1,101,000 | 0 | 1,000 | 0 | 10,000 | 0 | 443,000 | ||||||||||||||||||||||
other | 11,114,000 | 603,000 | 10,155,000 | -9,995,000 | -6,810,000 | -4,948,000 | 191,000 | 241,000 | 63,000 | 52,000 | 160,000 | 85,000 | 71,000 | 95,000 | 2,302,000 | 61,000 | 5,102,000 | 9,000 | 1,562,000 | 51,000 | 11,000 | 6,656,000 | 7,400,000 | -968,000 | -1,376,000 | -2,222,000 | -991,000 | -2,385,000 | ||||||||||||||||||||||||||||||||||||
purchase of common stock for treasury | -42,909,000 | -61,712,000 | -194,608,000 | -84,771,000 | -38,259,000 | -72,968,000 | -96,000 | -222,112,000 | -163,302,000 | -79,753,000 | -91,107,000 | -104,823,000 | -119,042,000 | -150,369,000 | -642,455,000 | -536,140,000 | -165,725,000 | -192,700,000 | -222,143,000 | -87,690,000 | -82,288,000 | -126,411,000 | -53,651,000 | -85,239,000 | -151,997,000 | -20,745,000 | -91,778,000 | -979,000 | -4,699,000 | -19,000 | -496,000 | 0 | -1,191,000 | -1,624,000 | 0 | -402,000 | -99,874,000 | |||||||||||||||||||||||||||
cash, cash equivalents and restricted cash—beginning of period | 0 | 1,259,748,000 | 0 | 0 | 0 | 746,210,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash—end of period | 214,767,000 | 799,131,000 | 289,737,000 | -59,672,000 | 210,426,000 | 819,257,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheet: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total cash, cash equivalents and restricted cash shown in the statement of cash flows | 214,767,000 | 799,131,000 | 289,737,000 | -59,672,000 | 210,426,000 | 819,257,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from finance receivables sold | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
excess tax benefits from share-based payments | 960,000 | 960,000 | 221,000 | 110,000 | 590,000 | 477,000 | 194,000 | 2,207,000 | 2,667,000 | 4,763,000 | 1,870,000 | 14,468,000 | -3,325,000 | 660,000 | 7,768,000 | 7,962,000 | 3,601,000 | -774,000 | 214,000 | 3,262,000 | 177,000 | 190,000 | 3,366,000 | 34,000 | 22,000 | 1,000 | 0 | 147,000 | 19,000 | 49,000 | ||||||||||||||||||||||||||||||||||
net decrease in credit facilities and unsecured commercial paper | -234,145,000 | -96,251,000 | -27,085,000 | -101,702,000 | 149,831,000 | -331,090,000 | -224,508,000 | -96,174,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of senior unsecured notes | -564,000 | 5,996,000 | -225,000 | -6,476,000 | 595,731,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net change in restricted cash | 4,691,000 | 11,015,000 | 15,884,000 | -23,132,000 | 12,514,000 | 12,989,000 | 22,274,000 | -4,282,000 | 26,575,000 | 24,994,000 | -11,580,000 | -28,579,000 | 20,234,000 | 26,924,000 | -14,979,000 | -9,017,000 | 29,392,000 | -28,836,000 | 58,431,000 | -17,340,000 | 8,553,000 | 5,852,000 | 50,843,000 | -6,016,000 | -1,274,000 | 56,982,000 | 56,680,000 | -34,734,000 | -40,205,000 | -50,804,000 | ||||||||||||||||||||||||||||||||||
effect of exchange rate changes on cash and cash equivalents | -2,070,000 | 16,360,000 | 5,238,000 | 7,219,000 | -16,143,000 | 2,782,000 | 837,000 | 3,081,000 | -1,011,000 | -7,971,000 | 3,324,000 | -9,019,000 | -11,290,000 | 1,991,000 | -7,525,000 | -10,629,000 | -10,094,000 | 8,643,000 | 8,802,000 | -23,181,000 | -13,122,000 | |||||||||||||||||||||||||||||||||||||||||||
net increase in cash and cash equivalents | 4,387,000 | -305,342,000 | 148,776,000 | 79,716,000 | -30,300,000 | -74,386,000 | 170,657,000 | -28,196,000 | 120,975,000 | 78,855,000 | 262,044,000 | -727,003,000 | 98,197,000 | -472,368,000 | 74,085,000 | -31,115,000 | -185,165,000 | 112,114,000 | 493,188,000 | 131,896,000 | 305,740,000 | 89,173,000 | -299,015,000 | |||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents—beginning of period | 0 | 0 | 0 | 759,984,000 | 0 | 0 | 0 | 722,209,000 | 0 | 0 | 0 | 906,680,000 | 0 | 1,066,612,000 | 0 | 1,068,138,000 | 0 | 0 | 0 | 1,630,433,000 | ||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents—end of period | 4,387,000 | -305,342,000 | 148,776,000 | 839,700,000 | -30,300,000 | -74,386,000 | 170,657,000 | 694,013,000 | -646,345,000 | 120,975,000 | 78,855,000 | 1,168,724,000 | -73,186,000 | 935,820,000 | 281,931,000 | 1,018,759,000 | -727,003,000 | 723,645,000 | -27,886,000 | 1,442,798,000 | ||||||||||||||||||||||||||||||||||||||||||||
repayment of senior unsecured notes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash (used by) provided by financing activities | -285,749,000 | -266,006,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net decrease in cash and cash equivalents | -73,186,000 | -130,792,000 | -49,379,000 | -204,841,000 | -250,613,000 | 40,963,000 | -89,418,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayments of senior unsecured notes | -303,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from (used by) financing activities | 143,996,000 | 57,190,000 | 157,161,000 | 553,681,000 | 685,073,000 | 29,125,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from | 203,586,000 | 525,168,000 | 200,842,000 | 97,958,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash (used by) provided by investing activities | -70,363,000 | -109,292,000 | -132,812,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from operating activities of continuing operations | 88,960,000 | 424,256,000 | -16,310,000 | 428,639,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash flows from investing activities of continuing operations: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash used by investing activities of continuing operations | -85,097,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash flows from financing activities of continuing operations: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash used by financing activities of continuing operations | -827,278,000 | 387,061,000 | -339,914,000 | -209,942,000 | 24,447,000 | -222,925,000 | -106,804,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net increase in cash and cash equivalents from continuing operations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash used by operating activities | -108,489,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from investing activities | 27,542,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net borrowings of asset-backed commercial paper | -17,063,000 | -31,015,000 | 154,900,000 | -67,194,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash (used) provided by investing activities of continuing operations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
dividends | -35,121,000 | -34,915,000 | -35,702,000 | -35,943,000 | -28,454,000 | -29,405,000 | -29,509,000 | -23,643,000 | -23,665,000 | -23,447,000 | -23,545,000 | -23,488,000 | -23,478,000 | -23,416,000 | -23,458,000 | -23,455,000 | -77,071,000 | -76,652,000 | ||||||||||||||||||||||||||||||||||||||||||||||
effect of exchange rate changes on cash and cash equivalents of continuing operations | -2,278,000 | -2,575,000 | -4,959,000 | 926,000 | 4,069,000 | -10,155,000 | 991,000 | -2,693,000 | 19,000 | 8,093,000 | -2,566,000 | -606,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
net increase in cash and cash equivalents of continuing operations | -727,003,000 | 98,123,000 | -469,945,000 | 120,064,000 | -22,000,000 | -170,414,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash flows from discontinued operations: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash flows from operating activities of discontinued operations | -10,000 | -25,000 | -2,423,000 | -46,640,000 | -8,287,000 | -13,723,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash flows from investing activities of discontinued operations | -393,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
effect of exchange rate changes on cash and cash equivalents of discontinued operations | 0 | 661,000 | -1,221,000 | -635,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents of discontinued operations—beginning of period | 0 | 6,063,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: cash and cash equivalents of discontinued operations—end of period | 3,229,000 | -8,533,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net repayments of asset-backed commercial paper | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net decrease in cash and cash equivalents of continuing operations | -204,841,000 | -250,613,000 | 40,973,000 | -89,393,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash used by operating activities of continuing operations | -73,616,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from investing activities of continuing operations | 32,019,000 | 125,022,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents - beginning of period | 1,526,950,000 | 0 | 0 | 1,021,933,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents of discontinued operations - beginning of period | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: cash and cash equivalents of discontinued operations - end of period | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents - end of period | 1,276,337,000 | 455,275,000 | 40,963,000 | 932,515,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
originations of finance receivables | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
collection of retained securitization interests | 15,327,000 | 18,939,000 | 25,546,000 | 1,358,000 | 18,368,000 | 56,772,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash (used by) provided by investing activities of continuing operations | 114,026,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of medium term notes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayment of medium term notes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net repayments in asset-backed commercial paper | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of common stock for treasury, net of issuances | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash (used by) provided by financing activities of continuing operations | -500,221,000 | -371,139,000 | -430,534,000 | -554,196,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents – beginning of period | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents of discontinued operations – beginning of period | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: cash and cash equivalents of discontinued operations – end of period | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents – end of period | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash flows used by operating activities of discontinued operations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
origination of finance receivables held for investment | -885,407,000 | -549,200,000 | -639,591,000 | -745,933,000 | -455,879,000 | -434,669,000 | -662,071,000 | -182,510,000 | -98,976,000 | -136,886,000 | -141,647,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
collections on finance receivables held for investment | 739,658,000 | 676,952,000 | 677,788,000 | 710,205,000 | 653,983,000 | 183,527,000 | 168,254,000 | 144,750,000 | 110,637,000 | 88,505,000 | 103,762,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from (used by) investing activities of continuing operations | 36,341,000 | 39,618,000 | -114,068,000 | 183,546,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net change in asset-backed commercial paper | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net (repayments) borrowings of asset-backed commercial paper | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayment of senior subordinated debt | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from (used by) financing activities of continuing operations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
acquisition of business, net of cash acquired | -330,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net increase in credit facilities and unsecured commerical paper | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
at beginning of period | 0 | 0 | 593,558,000 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
at end of period | 493,188,000 | 131,896,000 | 899,298,000 | 89,173,000 | -299,015,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of marketable securities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayment of medium-term notes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net decrease in finance-credit facilities and commercial paper | 30,102,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
revolving debt | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from (used by) investing activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net increase in finance-credit facilities and commercial paper | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash flows from operating activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
depreciation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
benefit from long-term employee benefits | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
benefit from share-based payments | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on current year securitizations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net change in wholesale finance receivables | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
origination of retail finance receivables held for sale | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
collections on retail finance receivables held for sale | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from securitization of retail finance receivables | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contributions to pension and postretirement plans | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
tax benefit from the exercise of stock options | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred income taxes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net changes in current assets and current liabilities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total adjustments | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of remaining interest in joint venture | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from (used) in investing activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
at beginning of year | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
at end of year | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
benefit from finance credit losses | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contributions to pension plans | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
finance receivables acquired or originated | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
finance receivables collected | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from securitizations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net increase finance credit facilities and commercial paper | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
depreciation and amortization | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current year gain on securitizations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net increase other finance debt | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on sale of credit card business | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term employee benefits | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
finance receivables sold | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net proceeds from sale of credit card business | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of italian distributor | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net increase in finance debt |
We provide you with 20 years of cash flow statements for Harley-Davidson stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Harley-Davidson stock. Explore the full financial landscape of Harley-Davidson stock with our expertly curated income statements.
The information provided in this report about Harley-Davidson stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.